Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

NCT04318366 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.

NCT NCT04318366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04318366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response
Lead sponsor
Università Vita-Salute San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
March 19, 2020
Completion date
June 19, 2026
Enrollment
6,000 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections